Lau Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Lau Associates's GILD Position: Q4 2018 in Review
Lau Associates sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,430 shares — an estimated $265K sold.
Lau Associates first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $3.35M in Q2 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.
- Lau Associates reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
- Lau Associates sold 3,430 Gilead Sciences shares in Q4 2018, an estimated $265K.
- Lau Associates first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
- Lau Associates's Gilead Sciences position peaked at $3.35M in Q2 2015.
- 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.
Based on Lau Associates's 13F filing for Q4 2018, filed 6 Feb 2019.